With limited vaccine doses, who would get them first?
It’s still unknown when a COVID-19 vaccine might be available in the United States. But when one is first approved, there may only be 10 million to 15 million doses available, which may be enough to cover around 3% to 5% of the U.S. population. That’s according to estimates... Read more
Medical care delayed during pandemic
A poll of households in the four largest U.S. cities by NPR, the Robert Wood Johnson Foundation and Harvard’s T.H. Chan School of Public Health finds roughly one in every five have had at least one member who was unable to get medical care or who has had to delay care... Read more
Amid vaccine trials, recruiting minority volunteers takes time
Black patients are some of the most reluctant to participate in clinical trials, according to FDA statistics. And their inclusion in the coronavirus vaccine trials has been a stated priority for the pharmaceutical companies involved, since African American communities, along with Latinos, have suffered disproportionately from the pandemic. But the trials... Read more
Scientists wonder how the flu and COVID-19 may mix
With the annual flu season about to start, it’s still unclear exactly how influenza virus will interact with the coronavirus if a person has both viruses. Read more
Extra pollution released before Laura’s landfall
The pollution began before the storm even made landfall. In the two days before the storm arrived, facilities in Texas released more than 4 million pounds of extra air pollution, according to reports the companies made to state environmental regulators that were analyzed by the nonprofit Environmental Defense Fund for NPR. Read more

Help us pursue our nonprofit mission with a tax-deductible donation.

Credit Cards

Donations Welcome

Donate Icon